South & Central America Cough Drops Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The cough drops market in South and Central America is projected to grow from US$ 133.89 million in 2023 to US$ 199.95 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.1% during this period.

Executive Summary and Market Analysis

The cough drops sector in South and Central America is witnessing steady growth, driven by increasing healthcare awareness and a cultural preference for natural remedies. Key markets such as Brazil, Argentina, and Colombia are at the forefront of this demand, influenced by factors like seasonal weather changes, urban pollution, and a heightened focus on self-care. Consumers are increasingly opting for herbal and plant-based lozenges, with popular ingredients including eucalyptus, honey, and guaco, a herb indigenous to the region. While international brands are expanding their presence, local manufacturers remain competitive by providing affordable products that resonate with traditional health practices. The growth of pharmacies and improved access to healthcare products in rural areas are also contributing to market expansion. Furthermore, the COVID-19 pandemic has intensified interest in preventive health measures and immune-boosting ingredients, shaping consumer preferences. As economic conditions stabilize and health consciousness rises, the cough drops market in the region is expected to continue its steady development in the coming years.

Market Segmentation Analysis

The South and Central America cough drops market can be segmented by product type, application, and distribution channel.

By Product: The market is divided into gluten-free, sugar-free, and other categories, with sugar-free cough drops holding the largest market share in 2023.
By Application: The market is categorized into adult and children segments, with adults representing a larger share in 2023.
By Distribution Channel: The market is split into offline and online channels, with offline sales dominating in 2023. The offline segment includes retail pharmacies, supermarkets or hypermarkets, and hospital pharmacies.

Market Outlook

Homemade herbal remedies have been utilized for centuries to treat coughs and sore throats. Recently, there has been a resurgence in interest in natural healing methods, prompting consumers to seek herbal cough drops, including blends featuring thyme or licorice root, as viable alternatives to conventional medications. Growing consumer awareness regarding health and wellness is driving demand for cough drops made with natural and organic ingredients. Many individuals are becoming increasingly cautious about the potential side effects of synthetic components in medications, leading to a preference for natural remedies that incorporate herbal extracts and organic flavors. Ingredients such as honey, ginger, and eucalyptus are gaining popularity due to their soothing properties for the throat. In response to this trend, manufacturers are investing in the development of cough drops that feature herbal extracts and organic flavors. For instance, in September 2023, Ricola launched a new line of cough drops that combine Swiss herbs, appealing to those who favor traditional herbal remedies. This global shift towards natural ingredients is not limited to developed markets; emerging economies are also experiencing a significant rise in demand for herbal and natural products. Manufacturers can capitalize on this trend by expanding their distribution networks into regions where natural remedies are culturally preferred. Additionally, as consumers become more environmentally conscious, companies that adopt sustainable practices in sourcing and packaging can differentiate themselves in the market. Utilizing eco-friendly materials and promoting the sustainable sourcing of natural ingredients can enhance brand loyalty among environmentally aware consumers. Therefore, the increasing emphasis on natural ingredients and sustainable packaging is expected to create substantial growth opportunities for the cough drops market in the near future.

Country Insights

The South and Central America cough drops market includes Brazil, Argentina, and other countries in the region, with Brazil holding the largest market share in 2023. The rise of e-commerce and retail pharmacies in Brazil is enhancing consumer accessibility, allowing for convenient purchases of cough drop products. Key distributors in Brazil include Kiosk Brazil and alltimetrading.com, among others. The availability of diverse brands and formulations has intensified competition, fostering innovation and marketing efforts within the sector. Additionally, seasonal variations in respiratory illnesses due to weather changes can lead to spikes in sales, providing opportunities for manufacturers to optimize their supply chains.

Company Profiles

Key players in the South and Central America cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.

Product Code: BMIRE00032013

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Cough Drops Market Landscape

4.1 Overview
4.2 PEST Analysis

5. South & Central America Cough Drops Market - Key Market Dynamics

5.1 South & Central America Cough Drops Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Burden of Respiratory Diseases Causing Soar Throat
- 5.2.2 Increasing Shift Toward Self-Medication
5.3 Market Restraints
- 5.3.1 Inability to Provide Long-Term Relief and Availability of Alternatives
5.4 Market Opportunities
- 5.4.1 Surging Focus on Natural Ingredients and Sustainable Packaging
5.5 Future Trends
- 5.5.1 Adoption of Innovative Marketing Strategies
5.6 Impact of Drivers and Restraints:

6. South & Central America Cough Drops Market - Analysis

6.1 South & Central America Cough Drops Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Cough Drops Market Forecast Analysis

7. South & Central America Cough Drops Market Analysis - by Product

7.1 Gluten Free
- 7.1.1 Overview
- 7.1.2 Gluten Free: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Sugar Free
- 7.2.1 Overview
- 7.2.2 Sugar Free: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Others
- 7.3.1 Overview
- 7.3.2 Others: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Cough Drops Market Analysis - by Application

8.1 Adults
- 8.1.1 Overview
- 8.1.2 Adults: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Children
- 8.2.1 Overview
- 8.2.2 Children: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Cough Drops Market Analysis - by Distribution Channel

9.1 Offline
- 9.1.1 Overview
- 9.1.2 Offline: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Online
- 9.2.1 Overview
- 9.2.2 Online: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Cough Drops Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Cough Drops Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Cough Drops Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Cough Drops Market Share - by Product
    - 10.1.1.2.2 Brazil: South & Central America Cough Drops Market Share - by Application
    - 10.1.1.2.3 Brazil: South & Central America Cough Drops Market Share - by Distribution Channel
    - 10.1.1.2.4 Brazil: South & Central America Cough Drops Market Share - by Offline
  - 10.1.1.3 Argentina: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Cough Drops Market Share - by Product
    - 10.1.1.3.2 Argentina: South & Central America Cough Drops Market Share - by Application
    - 10.1.1.3.3 Argentina: South & Central America Cough Drops Market Share - by Distribution Channel
    - 10.1.1.3.4 Argentina: South & Central America Cough Drops Market Share - by Offline
  - 10.1.1.4 Rest of South & Central America: South & Central America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Cough Drops Market Share - by Product
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Cough Drops Market Share - by Application
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Cough Drops Market Share - by Distribution Channel
    - 10.1.1.4.4 Rest of South & Central America: South & Central America Cough Drops Market Share - by Offline

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Cough Drops Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Mondelez International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 The Procter & Gamble Co
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 GSK Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Cipla Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bliss GVS Pharma Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thornton & Ross
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Reckitt Benckiser Group Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Financial Overview
- 12.7.4 SWOT Analysis
- 12.7.5 Key Developments
12.8 Sanofi SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Gepach International
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Ricola
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms